Global Hepatitis E Diagnostic Tests Market to reach USD 71.10 million by 2027

Global Hepatitis E Diagnostic Tests Market Size study, by Test type (HEV IgM ELISA Test kits, HEV IgG ELISA Test kits, RT-PCR Test kits and Others), By End-Users (Hospitals, Diagnostic Laboratories, Research Centers and Point of Care) and Regional Forecasts 2020-2027
Product Code:  HALMD_40493690
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Hepatitis E Diagnostic Tests Market, by Region, 2018-2027 (USD Billion)
1.2.2.	Hepatitis E Diagnostic Tests Market, by Test Type 2018-2027 (USD Billion)
1.2.3.	Hepatitis E Diagnostic Tests Market, by End-User 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Hepatitis E Diagnostic Tests Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Hepatitis E Diagnostic Tests Market Dynamics	
3.1.	Hepatitis E Diagnostic Tests Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Hepatitis E Diagnostic Tests Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Hepatitis E Diagnostic Tests Market, by Test Type
5.1.	Market Snapshot 
5.2.	Global Hepatitis E Diagnostic Tests Market by  Test Type , Performance - Potential Analysis
5.3.	Global Hepatitis E Diagnostic Tests Market Estimates & Forecasts by Test Type  2017-2027 (USD Billion)
5.4.	Hepatitis E Diagnostic Tests Market, Sub Segment Analysis
5.4.1.	  HEV IgM ELISA Test kits
5.4.2.	  HEV IgG ELISA Test kits
5.4.3.	 RT-PCR Test kits
5.4.4.	Others
Chapter 6.	Global Hepatitis E Diagnostic Tests Market, by End-User 
6.1.	Market Snapshot 
6.2.	Global Hepatitis E Diagnostic Tests Market by  End-User , Performance - Potential Analysis
6.3.	Global Hepatitis E Diagnostic Tests Market Estimates & Forecasts by End-User 2017 -2027 (USD Billion)
6.4.	Hepatitis E Diagnostic Tests Market, Sub Segment Analysis
6.4.1.	  Hospitals
6.4.2.	 Diagnostic Laboratories
6.4.3.	 Research Centers
6.4.4.	 Point of Care 
Chapter 7.	Global Hepatitis E Diagnostic Tests Market, Regional Analysis
7.1.	Hepatitis E Diagnostic Tests Market, Regional Market Snapshot 
7.2.	North America Hepatitis E Diagnostic Tests Market 
7.2.1.	U.S. Hepatitis E Diagnostic Tests Market
7.2.1.1.	Test Type breakdown estimates & forecasts, 2017-2027
7.2.1.2.	End-User breakdown estimates & forecasts, 2017-2027
7.2.2.	Canada Hepatitis E Diagnostic Tests Market
7.3.	Europe Hepatitis E Diagnostic Tests Market Snapshot
7.3.1.	U.K. Hepatitis E Diagnostic Tests Market 
7.3.2.	Germany Hepatitis E Diagnostic Tests Market
7.3.3.	France Hepatitis E Diagnostic Tests Market
7.3.4.	Spain Hepatitis E Diagnostic Tests Market
7.3.5.	Italy Hepatitis E Diagnostic Tests Market
7.3.6.	Rest of Europe Hepatitis E Diagnostic Tests Market
7.4.	Asia-Pacific Hepatitis E Diagnostic Tests Market Snapshot
7.4.1.	China Hepatitis E Diagnostic Tests Market 
7.4.2.	India Hepatitis E Diagnostic Tests Market 
7.4.3.	Japan Hepatitis E Diagnostic Tests Market
7.4.4.	Australia Hepatitis E Diagnostic Tests Market
7.4.5.	South Korea Hepatitis E Diagnostic Tests Market
7.4.6.	Rest of Asia Pacific Hepatitis E Diagnostic Tests Market
7.5.	Latin America Hepatitis E Diagnostic Tests Market Snapshot
7.5.1.	Brazil Hepatitis E Diagnostic Tests Market
7.5.2.	Mexico Hepatitis E Diagnostic Tests Market
7.6.	Rest of The World Hepatitis E Diagnostic Tests Market

Chapter 8.	Competitive Intelligence
8.1.	Top Market Strategies
8.2.	Company Profiles
8.2.1.	 altona Diagnostics GmbH 
8.2.1.1.	Key Information
8.2.1.2.	Overview
8.2.1.3.	Financial (Subject to Data Availability)
8.2.1.4.	Product Summary
8.2.1.5.	Recent Developments
8.2.2.	  Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
8.2.3.	 Biokit S.A.
8.2.4.	 Dia.Pro - Diagnostic Bioprobes s.r.l
8.2.5.	 F. Hoffmann-La Roche Ltd.
8.2.6.	Fast-track diagnostics Ltd.
8.2.7.	 Fortress Diagnostics Limited
8.2.8.	  Mikrogen GmBH
8.2.9.	 MP Biomedicals, LLC.
8.2.10.	Primerdesign Ltd. 
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.2.	Research Attributes
9.3.	Research Assumption

Global Hepatitis E Diagnostic Tests Market is valued approximately USD 50.00 million in 2019 and is anticipated to grow with a healthy growth rate of more than 4.50 % over the forecast period 2020-2027. Hepatitis E virus is the leading cause of acute viral hepatitis in the world mainly affecting the liver. Hepatitis E virus is considered as travel-associated infection. Diagnosis of HEV is based on the detection of viral RNA in the serums or feces. There is no specific treatment for hepatitis E. Analysis of HEV performed on RNA in biologic specimens such as liver biopsy, stools and serums are used for diagnostics. Further, government and health authority of various countries are also taking various efforts for making diagnostic tests available in the countries. A world Health Organization is focusing in making vaccine and diagnostic test available to reduce the global burden of disease. Also, the key players are focusing on strategies such as product launch, innovation and merger & acquisition to sustain themselves amidst fierce competition. The growth of the market is attributed owing to the increase in rise in prevalence of hepatitis-e disease along with the government initiative regarding awareness of hepatis E diagnosis. As per the World Health Organizations in July 2020, the WHO estimated that every year there were an estimated 20 million HEV infections worldwide, leading to a 3.3 million symptomatic cases of hepatitis E. As a result, the need for hepatitis e diagnostic tests would increase thereby, reinforcing the growth of the market during the forecast period of 2020-2027. However, high cost of diagnostics procedure and poor reimbursement policies may hinder growth of global Hepatitis E diagnostic tests market.

The regional analysis of global Hepatitis E Diagnostic Tests market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia-pacific is the leading/significant region due to the increasing incidence of Hepatitis E in some countries such as Nepal, Vietnam, Pakistan, Bangladesh, Burma, Kazakhstan, Thailand, and Bhutan of this region. Also, the dominance of the region is witnessed owing to the lack of proper sanitation and access to safe drinking water which may cause Hepatitis E. Whereas Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Altona Diagnostics GmbH
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Biokit S.A.
Dia.Pro – Diagnostic Bioprobes s.r.l
F. Hoffmann-La Roche Ltd.
Fast-track diagnostics Ltd.
Fortress Diagnostics Limited
Mikrogen GmBH
MP Biomedicals, LLC.
Primerdesign Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Test Type:
HEV IgM ELISA Test kits
HEV IgG ELISA Test kits
RT-PCR Test kits
Others

By End-User:
Hospitals
Diagnostic Laboratories
Research Centers
Point of Care

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Hepatitis E Diagnostic Tests Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…